High-Efficiency Disc Stack Centrifuge Technology for Biopharmaceutical Fermentation Broth Separation and Purification

With the rapid innovation and industrial upgrading of the global biopharmaceutical industry, the production standards for biological drugs, health care raw materials, and microbial active ingredients have become increasingly stringent. Modern biopharmaceutical manufacturing requires separation and purification processes that can maintain biological activity, remove miscellaneous impurities efficiently, and support continuous large-scale production. Traditional fermentation broth separation methods, including static gravity sedimentation and conventional filter media filtration, have prominent limitations. These conventional processes suffer from low separation efficiency, long production cycles, high residual solid impurities, and inevitable loss of heat-sensitive active substances. In addition, frequent filter cloth replacement and manual cleaning lead to unstable batch consistency and increased production costs, which can no longer meet the high-standard purification requirements of monoclonal antibodies, enzymes, microbial polysaccharides, and other high-value biopharmaceutical products. Against this backdrop, high-performance disc stack centrifuge technology has emerged as the preferred solution for biopharmaceutical downstream purification, relying on its high centrifugal force separation, mild operating conditions, and fully continuous industrial processing capabilities.

Industrial disc stack centrifuges are high-precision dynamic separation equipment designed based on the density difference separation principle. Different from static filtration and sedimentation, the equipment generates powerful centrifugal force through high-speed rotation, which rapidly stratifies fermentation broth components with different densities. During operation, solid impurities such as thallus residues, culture medium sediments, and macromolecular denatured proteins are rapidly separated and settled, while active liquid ingredients including target proteins, microbial metabolites, and antibody stock solutions are efficiently clarified and retained. The built-in dense disc stack structure greatly increases the separation settling area, effectively improving separation precision and processing capacity. This technology perfectly solves the pain points of incomplete impurity removal and low product recovery rate in traditional fermentation broth treatment, providing a reliable and efficient technical carrier for the purification and concentration of biopharmaceutical raw materials.

Our factory independently designs and manufactures industrial-grade disc stack centrifuge systems tailored for biopharmaceutical scenarios, covering core application links such as fermentation broth clarification, thallus separation, active ingredient concentration, and liquid impurity removal. The full skid-mounted integrated system adopts sanitary-grade stainless steel overall structure, equipped with high-precision disc stack modules, variable frequency speed regulation systems, automatic slag discharge devices, closed sterile pipelines, and fully automatic CIP online cleaning systems. The equipment complies with GMP production standards for biopharmaceuticals, realizing fully enclosed sterile operation throughout the whole process and effectively avoiding external microbial contamination and product cross-contamination. Through optimized dynamic centrifugal separation technology, the system achieves continuous feeding, real-time separation, automatic slag discharge, and online cleaning, ensuring long-term stable and uninterrupted industrial production.

Compared with traditional fermentation broth separation processes, disc stack centrifuge systems show overwhelming technical and economic advantages in biopharmaceutical processing. First of all, the whole separation process is carried out at low temperature and normal pressure without phase change and mechanical extrusion damage, which fully protects the biological activity of heat-sensitive target ingredients such as antibodies and enzymes and greatly reduces product activity loss. Secondly, the high centrifugal force separation mode realizes thorough separation of micro-fine impurities and thallus residues, with the clarification purity far exceeding that of traditional filtration processes, effectively improving the purity and quality stability of finished biopharmaceutical products. In addition, the fully automatic continuous operation mode eliminates frequent replacement of filter media and manual intervention, significantly improving production efficiency, shortening downstream processing cycles, and reducing labor costs and material consumption costs. Moreover, the closed sterile operating system effectively meets the strict sanitary production requirements of the biopharmaceutical industry, avoiding product quality risks caused by secondary pollution.

In the core production link of biological drug raw materials, disc stack centrifuges play an irreplaceable role in the purification of monoclonal antibody fermentation broth, microbial enzyme liquid, and amino acid stock solution. After the fermentation culture is completed, the crude fermentation broth contains a large number of thallus cells, residual culture medium, and metabolic impurities. After being treated by the disc stack centrifuge system, solid-phase impurities are automatically separated and discharged, and the clarified liquid phase can directly enter the ultrafiltration concentration and chromatographic purification process. By adjusting the rotating speed, feeding flow rate, and slag discharge cycle parameters, the equipment can adapt to fermentation broths of different concentrations and impurity contents, realizing customized high-precision separation. The high-purity clarified liquid obtained after centrifugal separation effectively reduces the operating pressure of subsequent fine purification equipment, extends the service life of chromatographic media and membrane modules, and further improves the overall yield and production efficiency of high-value biological products.

In the field of functional biological raw material processing, disc stack centrifuge technology also provides efficient solutions for the clarification and purification of plant fermentation extracts, microbial polysaccharides, and biological preservatives. The equipment can selectively remove invalid impurities and retain active functional components, ensuring the batch consistency and stability of biological raw materials. Different from traditional process equipment, industrial centrifugal separation equipment has adjustable separation precision and strong process adaptability, which can meet the diversified production needs of laboratory pilot scale to large-scale industrial production. It effectively solves the problems of unstable product quality and low raw material utilization rate in traditional biological processing, and helps enterprises produce high-purity functional biological ingredients for pharmaceutical preparations, high-end health products, and functional food markets.

The standard operating process of the biopharmaceutical disc stack centrifuge system includes raw liquor pretreatment, constant-pressure feeding, high-speed centrifugal stratification, automatic solid-liquid separation, regular automatic slag discharge, and CIP online sterile cleaning. During formal operation, the pretreated fermentation broth is stably delivered to the centrifugal separation chamber through a sterile delivery pump. Under the action of high-speed centrifugal force, solid impurities settle on the inner wall of the equipment and are discharged through the automatic slag discharge system, while the clarified active liquid is output stably. When the equipment operates for a preset cycle, the fully automatic CIP cleaning system starts online flushing and sterilization to remove residual material dirt, ensuring the sterile state of the equipment and the stability of subsequent separation effects, and realizing long-term continuous and reliable industrial production.

With the continuous growth of global demand for high-purity biopharmaceutical products and the continuous upgrading of green and low-carbon production concepts, biopharmaceutical disc stack centrifuge separation technology has become a core key technology to optimize downstream processing processes, improve product yield, and reduce production energy consumption. Compared with traditional separation processes, disc stack centrifuges have significant comprehensive advantages in product activity protection, separation precision, production continuity, and operating cost control, and are more in line with the development trend of modern intelligent and sterile biopharmaceutical production.

Our company provides customized biopharmaceutical centrifugal separation solutions for different fermentation raw materials, processing scales, and finished product purity standards. We provide one-stop technical services from laboratory process verification, pilot scale-up to full industrial production system customization and installation debugging. We help global biopharmaceutical enterprises optimize downstream purification processes, maximize the recovery rate of high-value biological ingredients, reduce comprehensive production costs, and create higher market value for biological pharmaceutical and functional biological product manufacturing.